One of the most dreaded complications after COVID-19 vaccination is transverse myelitis and other similar illnesses that leave the victim paralyzed. I interviewedCheng MY, Ho HC, Hsu JL, Wang Y, Chen L, Lim SN, Liao MF, Ro LS. Clinical Research into Central Nervous System Inflammatory Demyelinating Diseases Related to COVID-19 Vaccines. Diseases. 2024 Mar 20;12(3):60. doi: 10.3390/diseases12030060. PMID: 38534984; PMCID: PMC10969393.
“Among 79 patients with COVID-19 vaccine-related CNS IDDs, 49 (62%) cases received viral vector vaccines, 20 (25.3%) received mRNA vaccines, and 10 (12.7%) received inactivated vaccines. Twenty-seven cases (34.2%) were confirmed with autoantibodies, including fifteen patients (19%) with anti-myelin oligodendrocyte glycoprotein, eleven (13.9%) with anti-aquaporin 4 (AQP4), and one (1.3%) with both antibodies.”
The main teaching point is to get the appropriate blood tests when faced with a new paralytic syndrome after COVID-19 vaccination. Given the poor prognosis, a full-court press on immunomodulatory therapy and McCullough Protocol Base Spike Detoxification is warranted.
Courageous Discourse™ with Dr. Peter McCullough & John Leake is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
Please subscribe to Courageous Discourse as a paying or founder member so we can continue to bring you the truth.
This content is courtesy of, and owned and copyrighted by, https://petermcculloughmd.substack.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.